Showing results (1-10 of 56) with videos related to
Sort By:
Pageof 6
Journal of Immune Based Therapies and Vaccines|January 14, 2011
Dendritic cell therapy for oncology roundtable conferenceSandra TuyaertsVaccines|August 29, 2018
Endometrial Stromal Sarcomas: A Revision of Their Potential as Targets for ImmunotherapySandra Tuyaerts, Frédéric AmantSarcoma|November 18, 2015
Potential Therapeutic Targets in Uterine SarcomasTine Cuppens, Sandra Tuyaerts, Frédéric AmantInternational Journal of Molecular Sciences|July 26, 2019
Contribution of Aging, Obesity, and Microbiota on Tumor Immunotherapy Efficacy and ToxicityRegina E M Baiden-Amissah, Sandra TuyaertsFrontiers in Immunology|June 5, 2023
Overcoming the immune suppressive nature of glioblastoma by leveraging the surgical intervention - current status and future perspectivesJohnny Duerinck, Sandra Tuyaerts, Kiavash Movahedi, et al.Current Opinion in Oncology|February 1, 2023
Current "state of the art" on dendritic cell-based cancer vaccines in melanomaJulia Katharina Schwarze, Xenia Geeraerts, Sandra Tuyaerts, et al.Cancer Immunology, Immunotherapy : CII|March 25, 2014
Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapyAnke Vanderstraeten, Catherine Luyten, Godelieve Verbist, et al.Cancers|April 30, 2021
Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types?Wout De Wispelaere, Daniela Annibali, Sandra Tuyaerts, et al.Cancers|August 27, 2021
Endometrial Cancer Molecular Characterization: The Key to Identifying High-Risk Patients and Defining Guidelines for Clinical Decision-Making?Regina Esi Mensimah Baiden-Amissah, Daniela Annibali, Sandra Tuyaerts, et al.Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Delivery of tumor-antigen-encoding mRNA into dendritic cells for vaccinationAnnelies Michiels, Sandra Tuyaerts, Aude Bonehill, et al.Pageof 6